Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Does multiple sclerosis affect glucose tolerance?
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Early detection of MS treatment complication may improve survival
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
Relationship between vitamin D and depression in multiple sclerosis.
Feedforward postural control in individuals with multiple sclerosis during load release.
Increasing age at disability milestones among MS patients in the MSBase Registry.
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Afferent visual pathways in multiple sclerosis: a review.
Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
[Anti-NMDA receptor encephalitis - case report].

Pages